Replies to post #146465 on Biotech Values

[DewDiligence]

Enanta Pharmaceuticals files for IPO:

http://finance.yahoo.com/news/enanta-pharmaceuticals-files-registration-statement-222100930.html

Enanta is a player in HCV, having licensed ABT-450, a protease inhibitor, to ABT (#msg-15492225) and EDP-239, an NS5A inhibitor, to NVS (#msg-72334186).